Literature DB >> 7646815

Role of the transcription factor C/EBP beta in expression of a rat pregnancy-specific glycoprotein gene.

H Chen1, B Lin, C L Chen, P F Johnson, J Y Chou.   

Abstract

Pregnancy-specific glycoproteins (PSGs), which are the major placental proteins, and the carcinoembryonic antigens comprise a subfamily within the immunoglobulin superfamily. To understand the molecular mechanisms underlying the control of PSG expression, we characterized the promoter elements of a rodent PSG gene, rnCGM3, and showed that DNA elements at nucleotides -326 to -185 (PI) relative to the translation start site of rnCGM3 function as a promoter. The rnCGM3 PI promoter contains two placental factor binding sites, PISI and PISII. Both are transcription activation elements. In the present report, we screened a placental expression cDNA library with a rnCGM3-PISII probe (nucleotides -263 to -233) encompassing two overlapping palindromes (TGTTGCTCAACATGTTG) and demonstrated that the PISII-binding factor is C/EBP beta, a leucine zipper family of transcription factor. Gel mobility-shift and transient expression analyses showed that C/EBP beta and C/EBP isoforms, C/EBP alpha and C/EBP delta, bind to the PISII element and trans-activate rnCGM3 gene expression. Deletion of PISII from the rnCGM3 PI promoter greatly reduced the basal as well as the C/EBP-activated rnCGM3 expression. Gel supershift assays demonstrated that C/EBP beta is the placental isoform that binds to the PISII site rnCGM3. Moreover, C/EBP beta is expressed in high levels in the placenta, ovary, liver, lung, heart, and spleen, in contrast to C/EBP alpha, which is expressed primarily in the liver and only low levels in the placenta. Our results demonstrate that C/EBP beta is one of the transcription factors that positively regulate rnCGM3 expression during pregnancy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7646815     DOI: 10.1089/dna.1995.14.681

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  5 in total

1.  Selective activation of trophoblast-specific PLAC1 in breast cancer by CCAAT/enhancer-binding protein beta (C/EBPbeta) isoform 2.

Authors:  Michael Koslowski; Ozlem Türeci; Stefan Biesterfeld; Gerhard Seitz; Christoph Huber; Ugur Sahin
Journal:  J Biol Chem       Date:  2009-08-03       Impact factor: 5.157

2.  The C/EBPbeta transcription factor regulates epithelial cell proliferation and differentiation in the mammary gland.

Authors:  G W Robinson; P F Johnson; L Hennighausen; E Sterneck
Journal:  Genes Dev       Date:  1998-06-15       Impact factor: 11.361

3.  Expression pattern of the CCAAT/enhancer-binding proteins C/EBP-alpha, C/EBP-beta and C/EBP-delta in the human placenta.

Authors:  Ana-Maria Bamberger; Antonis Makrigiannakis; Martina Schröder; Christoph M Bamberger; Constantine Relakis; Birgit Gellersen; Karin Milde-Langosch; Thomas Löning
Journal:  Virchows Arch       Date:  2003-12-23       Impact factor: 4.064

4.  CCAAT-enhancer-binding protein β (C/EBPβ) and downstream human placental growth hormone genes are targets for dysregulation in pregnancies complicated by maternal obesity.

Authors:  Hana Vakili; Yan Jin; Savas Menticoglou; Peter A Cattini
Journal:  J Biol Chem       Date:  2013-06-19       Impact factor: 5.157

5.  Insulin-like growth factor axis in pregnancies affected by fetal growth disorders.

Authors:  Aamod R Nawathe; Mark Christian; Sung Hye Kim; Mark Johnson; Makrina D Savvidou; Vasso Terzidou
Journal:  Clin Epigenetics       Date:  2016-01-27       Impact factor: 6.551

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.